OATP1B1 in vitro inhibition assay enrichment & QSAR modeling

被引：0
|
作者：
Danielson, Matthew [1 ]
机构：
[1] Eli Lilly & Co, Indianapolis, IN 46285 USA
来源：
DRUG METABOLISM REVIEWS | 2016年 / 48卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
P169
引用
收藏
页码：107 / 107
页数：1
相关论文
共 50 条
  • [1] In Silico and in Vitro Assessment of OATP1B1 Inhibition in Drug Discovery
    Danielson, Matthew L.
    Sawada, Geri A.
    Raub, Thomas J.
    Desai, Prashant V.
    MOLECULAR PHARMACEUTICS, 2018, 15 (08) : 3060 - 3068
  • [2] The Development, Characterization, and Application of an OATP1B1 Inhibition Assay in Drug Discovery
    Soars, Matthew G.
    Barton, Patrick
    Ismair, Manfred
    Jupp, Rachael
    Riley, Robert J.
    DRUG METABOLISM AND DISPOSITION, 2012, 40 (08) : 1641 - 1648
  • [3] Characteization of OATP1B1 and OATP1B3 inhibition by Nilotinib
    Sprowl, Jason A.
    Chen, Mingqing
    Gibson, Alice A.
    Pasquariello, Kyle Z.
    Sparreboom, Alex
    Hu, Shuiying
    FASEB JOURNAL, 2019, 33
  • [4] Inhibition of OATP1B1 by tyrosine kinase inhibitors: in vitro–in vivo correlations
    S Hu
    R H J Mathijssen
    P de Bruijn
    S D Baker
    A Sparreboom
    British Journal of Cancer, 2014, 110 : 894 - 898
  • [5] Establishing the Competitive Counterflow Assay for OATP1B1 and OATP1B3
    Katuwal, Miki
    Schnegelberger, Regina
    Wityk, Elliott
    Ruggiero, Melissa
    Hagenbuch, Bruno
    FASEB JOURNAL, 2016, 30
  • [6] INHIBITION OF OATP1B1 BY GLUCURONIDES: DOES IN VITRO TRANSLATE TO IN VIVO RELEVANCE?
    Sulivan, Rebecca A.
    Galetin, Aleksandra
    Sharma, Pradeep
    Rollison, Helen
    Fenner, Katherine
    DRUG METABOLISM REVIEWS, 2015, 47 : 117 - 117
  • [7] In vitro OATP1B1 and OATP1B3 inhibition is associated with observations of benign clinical unconjugated hyperbilirubinemia
    Chiou, William J.
    de Morais, Sonia M.
    Kikuchi, Ryota
    Voorman, Richard L.
    Li, Xiaofeng
    Bow, Daniel A. J.
    XENOBIOTICA, 2014, 44 (03) : 276 - 282
  • [8] Inhibition of OATP1B1 by tyrosine kinase inhibitors: in vitro-in vivo correlations
    Hu, Shuiying
    Bruijn, Peter D.
    Mathijssen, Ron H. J.
    Baker, Sharyn D.
    Sparreboom, Alex
    CANCER RESEARCH, 2014, 74 (19)
  • [9] Inhibition of OATP1B1 by tyrosine kinase inhibitors: in vitro-in vivo correlations
    Hu, S.
    Mathijssen, R. H. J.
    de Bruijn, P.
    Baker, S. D.
    Sparreboom, A.
    BRITISH JOURNAL OF CANCER, 2014, 110 (04) : 894 - 898
  • [10] The application of An OATP1B1 inhibition assay within drug discovery: Use of in vitro and in silico approaches to aid drug design
    Soars, Matt G.
    Barton, Patrick
    Grime, Ken
    Riley, Robert J.
    DRUG METABOLISM REVIEWS, 2009, 41 : 178 - 178
12345